Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam conversion-to-monotherapy study in partial-onset seizures
2008-000145-58Phase 3Terminated
- Sponsor
- UCB
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brivaracetam in epilepsy and Focal onset seizure (2 arms), sponsored by UCB. Primary endpoints: Efficacy and Safety and tolerability. Started May 2008; status: terminated.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on 2008-000145-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000145-58.